- Home
- LDTC vs ENZ Comparison
LDTC vs ENZ Comparison
Compare LDTC & ENZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDTC
- ENZ
- Stock Information
- Founded
- LDTC 2007
- ENZ 1976
- Country
- LDTC Canada
- ENZ United States
- Employees
- LDTC N/A
- ENZ N/A
- Industry
- LDTC Blank Checks
- ENZ Medical Specialities
- Sector
- LDTC Finance
- ENZ Health Care
- Exchange
- LDTC Nasdaq
- ENZ Nasdaq
- Market Cap
- LDTC 37.5M
- ENZ 34.2M
- IPO Year
- LDTC N/A
- ENZ N/A
- Fundamental
- Price
- LDTC $0.43
- ENZ $0.49
- Analyst Decision
- LDTC Buy
- ENZ
- Analyst Count
- LDTC 2
- ENZ 0
- Target Price
- LDTC $3.00
- ENZ N/A
- AVG Volume (30 Days)
- LDTC 168.6K
- ENZ 625.0K
- Earning Date
- LDTC 05-13-2025
- ENZ 06-12-2025
- Dividend Yield
- LDTC N/A
- ENZ N/A
- EPS Growth
- LDTC N/A
- ENZ N/A
- EPS
- LDTC N/A
- ENZ N/A
- Revenue
- LDTC $331,997.00
- ENZ $29,094,000.00
- Revenue This Year
- LDTC $906.25
- ENZ N/A
- Revenue Next Year
- LDTC $149.88
- ENZ N/A
- P/E Ratio
- LDTC N/A
- ENZ N/A
- Revenue Growth
- LDTC 141.86
- ENZ N/A
- 52 Week Low
- LDTC $0.22
- ENZ $0.25
- 52 Week High
- LDTC $2.75
- ENZ $1.27
- Technical
- Relative Strength Index (RSI)
- LDTC 46.01
- ENZ 61.50
- Support Level
- LDTC $0.36
- ENZ $0.31
- Resistance Level
- LDTC $0.42
- ENZ $0.55
- Average True Range (ATR)
- LDTC 0.07
- ENZ 0.08
- MACD
- LDTC 0.01
- ENZ 0.02
- Stochastic Oscillator
- LDTC 37.34
- ENZ 79.87
About LDTC LeddarTech Holdings Inc.
LeddarTech Holdings Inc is a company that develops and provides comprehensive perception software solutions that enable the deployment of ADAS and autonomous driving (AD) applications. Its automotive-grade software applies AI and computer vision algorithms to generate accurate 3D models of the environment, allowing for decision-making and safer navigation. The company generates the majority of its revenue from France, Canada, and the United states.
About ENZ Enzo Biochem Inc. ($0.01 Par Value)
Enzo Biochem Inc is a bioscience company. The firm manufactures, develops and sell their proprietary solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians internationally. The company has one reportable segment, Products, which focuses on labeling and detection technologies from DNA to whole cell analysis, including a comprehensive portfolio of thousands of high-quality products, including antibodies, genomic probes, assays, biochemicals, and proteins.